Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2024-04-12 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Compliance Certificate reg 7 (3) for the period ending Mar 2024
Regulatory Filings
2024-04-12 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2024-04-08 English
Compliance certificate under reg 76(5) of SEBI (DP) REgulations 2018
Regulatory Filings
2024-04-08 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any descriptive text to classify as a specific report type. Given the lack of information, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2024-04-03 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It declares that the promoter group has not made any encumbrance of shares during the financial year ended 31st March 2024. This is a notification related to shareholding and encumbrance status, which fits the category of Major Shareholding Notification (MRQ). The document is short and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a report publication announcement or a certification. Therefore, the best classification is Major Shareholding Notification (MRQ).
2024-04-01 English
Change in Director(s)
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding changes in the company's board of directors. It specifically mentions the end of the second term of certain Independent Directors and provides the revised composition of the Board of Directors effective from a future date. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about changes in directors or key managerial personnel. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcements about changes in the company's board of directors or senior management.
2024-03-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.